A non-invasive Polymerase Chain Reaction (PCR) molecular diagnostic procedure to detect Helicobacter Pylori
Spartan Bioscience is a leading biotechnology company located in Ottawa, ON, which develops point-of-care medical device platforms for DNA diagnostics. Through this collaboration with Dr. Frank Merante from Seneca’s School of Biological Sciences and Applied Chemistry, Spartan will expand their product offering to include a non-invasive test for H. Pylori, the cause of 60% of all stomach cancers, and the third leading cause of cancer death in China. Spartan will sell this new diagnostic test into China, opening up a new international market for the company.
Funder: Natural Sciences and Engineering Research Council of Canada (NSERC).